Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
M/I Homes
MHO
$3.84B
| $3.5M | ﹤0.01% |
59,725
-14,103
| -19% | -$910K |
|
1802
Agree Realty
ADC
$9.41B
| $3.49M | ﹤0.01% |
49,490
-43,787
| -47% | -$3.07M |
|
1803
CALL
StoneCo
STNE
$2.58B
| $3.49M | ﹤0.01% |
+52,000
| New | +$3.37M |
|
1804
International Bancshares
IBOC
$4.57B
| $3.48M | ﹤0.01% |
81,152
+18,393
| +29% | +$859K |
|
1805
Urban One Class D
UONEK
$23.8M
| $3.47M | ﹤0.01% |
69,167
+49,261
| +247% | +$1.73M |
|
|
JJU
1806
DELISTED
iPath Series B Bloomberg Aluminum Subindex Total ReturnSM ETN
JJU
| $3.46M | ﹤0.01% |
65,000
-15,000
| -19% | -$766K |
|
|
TWTR
1807
PUT
DELISTED
Twitter, Inc.
TWTR
| $3.46M | ﹤0.01% |
50,300
-536,500
| -91% | -$32.9M |
|
1808
PUT
Range Resources
RRC
$8.95B
| $3.46M | ﹤0.01% |
206,400
+76,500
| +59% | +$960K |
|
1809
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $3.46M | ﹤0.01% |
63,678
+6,679
| +12% | +$356K |
|
1810
Banner Corp
BANR
$2.4B
| $3.46M | ﹤0.01% |
63,737
-6,175
| -9% | -$350K |
|
1811
Portland General Electric
POR
$5.77B
| $3.45M | ﹤0.01% |
74,883
-23,260
| -24% | -$1.14M |
|
1812
Wendy's
WEN
$1.46B
| $3.44M | ﹤0.01% |
146,898
-96,318
| -40% | -$2.21M |
|
1813
Urban Edge Properties
UE
$2.73B
| $3.44M | ﹤0.01% |
179,928
-97,993
| -35% | -$1.85M |
|
1814
Assured Guaranty
AGO
$3.34B
| $3.44M | ﹤0.01% |
72,362
-50,103
| -41% | -$2.35M |
|
1815
Dana Inc
DAN
$3.06B
| $3.43M | ﹤0.01% |
144,374
-301,929
| -68% | -$7.83M |
|
1816
Fiverr
FVRR
$339M
| $3.42M | ﹤0.01% |
14,124
-32,681
| -70% | -$6.78M |
|
1817
iShares MSCI Hong Kong ETF
EWH
$1.22B
| $3.42M | ﹤0.01% |
127,959
+57,230
| +81% | +$1.56M |
|
1818
Qualys
QLYS
$6.35B
| $3.42M | ﹤0.01% |
33,938
+1,185
| +4% | +$121K |
|
1819
CRISPR Therapeutics
CRSP
$5.17B
| $3.4M | ﹤0.01% |
21,024
+15,224
| +262% | +$1.85M |
|
1820
Chemours
CC
$2.37B
| $3.4M | ﹤0.01% |
97,663
+36,400
| +59% | +$1.21M |
|
1821
Gaming and Leisure Properties
GLPI
$12.8B
| $3.39M | ﹤0.01% |
73,264
-25,761
| -26% | -$1.18M |
|
|
GBT
1822
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.39M | ﹤0.01% |
96,771
+20,722
| +27% | +$809K |
|
|
SASR
1823
DELISTED
Sandy Spring Bancorp Inc
SASR
| $3.38M | ﹤0.01% |
76,674
-14,839
| -16% | -$673K |
|
1824
PUT
Axsome Therapeutics
AXSM
$10.9B
| $3.37M | ﹤0.01% |
+50,000
| New | +$3M |
|
|
FOE
1825
DELISTED
Ferro Corporation
FOE
| $3.37M | ﹤0.01% |
156,310
+45,615
| +41% | +$897K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.